90 related articles for article (PubMed ID: 1987306)
1. Chronic hypomagnesemia caused by cisplatin: effect of calcitriol.
Sutton RA; Walker VR; Halabe A; Swenerton K; Coppin CM
J Lab Clin Med; 1991 Jan; 117(1):40-3. PubMed ID: 1987306
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
[TBL] [Abstract][Full Text] [Related]
4. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
[TBL] [Abstract][Full Text] [Related]
5. Serum calcitriol and parathyroid hormone levels following prolonged infusion of calcitriol in vitamin D replete and depleted rabbits.
Long JF; Steinmeyer CL; Thornton DJ; Nagode LA
Res Commun Chem Pathol Pharmacol; 1989 May; 64(2):273-86. PubMed ID: 2740619
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone and calcitriol changes in normal and insulin-dependent diabetic pregnancies.
Mimouni F; Tsang RC; Hertzberg VS; Neumann V; Ellis K
Obstet Gynecol; 1989 Jul; 74(1):49-54. PubMed ID: 2733941
[TBL] [Abstract][Full Text] [Related]
7. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
8. Hypomagnesemia masking the appearance of elevated parathyroid hormone concentrations in familial pseudohypoparathyroidism.
Allen DB; Friedman AL; Greer FR; Chesney RW
Am J Med Genet; 1988 Sep; 31(1):153-8. PubMed ID: 3223496
[TBL] [Abstract][Full Text] [Related]
9. Interrelation between plasma magnesium and 25 hydroxy-vitamin D3 levels in chronic renal failure.
Shany S; Kushelevsky A; Berlyne GM
Biomedicine; 1977 Apr; 26(2):108-11. PubMed ID: 871518
[TBL] [Abstract][Full Text] [Related]
10. Serum vitamin D metabolites and bone mineralization in young children with chronic low to moderate lead exposure.
Koo WW; Succop PA; Bornschein RL; Krug-Wispe SK; Steinchen JJ; Tsang RC; Berger OG
Pediatrics; 1991 May; 87(5):680-7. PubMed ID: 2020514
[TBL] [Abstract][Full Text] [Related]
11. Calcium metabolism and calciotropic hormone levels in Gitelman's syndrome.
Colussi G; Macaluso M; Brunati C; Minetti L
Miner Electrolyte Metab; 1994; 20(5):294-301. PubMed ID: 7700218
[TBL] [Abstract][Full Text] [Related]
12. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of calcitriol and parathyroid hormone on serum aluminum in vitamin D-depleted rabbits fed an aluminum-supplemented diet.
Long JF; Nagode LA; Steinmeyer CL; Renkes G
Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):3-14. PubMed ID: 8165367
[TBL] [Abstract][Full Text] [Related]
14. Severe renal osteodystrophy without elevated serum immunoreactive parathyroid hormone concentrations in hypomagnesemia due to renal magnesium wasting.
Zelikovic I; Dabbagh S; Friedman AL; Goelzer ML; Chesney RW
Pediatrics; 1987 Mar; 79(3):403-9. PubMed ID: 3822640
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
16. Regulation of parathyroid hormone and vitamin D in essential hypertension.
Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients.
Liou HH; Chiang SS; Huang TP; Shieh SD; Akmal M
Miner Electrolyte Metab; 1994; 20(3):97-102. PubMed ID: 7816008
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced hypocalcemia and hypomagnesemia.
Lyman NW; Hemalatha C; Viscuso RL; Jacobs MG
Arch Intern Med; 1980 Nov; 140(11):1513-4. PubMed ID: 7192079
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
[TBL] [Abstract][Full Text] [Related]
20. Hypomagnesaemia after small bowel resection: treatment with 1 alpha-hydroxylated vitamin D metabolites.
Selby PL; Peacock M; Bambach CP
Br J Surg; 1984 May; 71(5):334-7. PubMed ID: 6547069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
